116 related articles for article (PubMed ID: 26885736)
1. Case 227: Endobronchial Carcinoid Tumor with Incidental Metastatic Breast Cancer Detected with Somatostatin Receptor Scintigraphy ((111)In Pentreotide).
Raslan OA; Parkar ND; Muzaffar R; Doherty C; Osman MM
Radiology; 2016 Mar; 278(3):949-55. PubMed ID: 26885736
[TBL] [Abstract][Full Text] [Related]
2. Growth of a solitary pulmonary nodule after 6years diagnosed as oncocytic carcinoid tumour with a high 18-fluorodeoxyglucose (18F-FDG) uptake in positron emission tomography-computed tomography (PET-CT).
Turan O; Ozdogan O; Gurel D; Onen A; Kargi A; Sevinc C
Clin Respir J; 2013 Jan; 7(1):e1-5. PubMed ID: 22129499
[TBL] [Abstract][Full Text] [Related]
3. Differentiation between carcinoid and sarcoid with F-18 FDG PET and In-111 pentetreotide.
Avram AM; Mackie GC; Schneider BJ; Kalemkerian GP; Shulkin BL
Clin Nucl Med; 2006 Apr; 31(4):197-200. PubMed ID: 16550010
[TBL] [Abstract][Full Text] [Related]
4. Unexpected slight fluorodeoxyglucose-uptake on positron emission tomography in a pulmonary hamartoma.
Himpe U; Deroose CM; Leyn PD; Verbeken E; Vansteenkiste J
J Thorac Oncol; 2009 Jan; 4(1):107-8. PubMed ID: 19096317
[TBL] [Abstract][Full Text] [Related]
5. Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography.
Koopmans KP; Neels OC; Kema IP; Elsinga PH; Sluiter WJ; Vanghillewe K; Brouwers AH; Jager PL; de Vries EG
J Clin Oncol; 2008 Mar; 26(9):1489-95. PubMed ID: 18349401
[TBL] [Abstract][Full Text] [Related]
6. F-18 FDG positron emission tomography demonstration of pulmonary carcinoid.
Jain M; Yung E; Trow T; Katz DS
Clin Nucl Med; 2004 Jun; 29(6):370-1. PubMed ID: 15166885
[No Abstract] [Full Text] [Related]
7. Multimodality imaging features in a case of bronchial carcinoid including FDG PET.
Shin V; Bhargava P; Brown J; Ames ED; Kang P
Med Sci Monit; 2007 Jan; 13(1):CS4-8. PubMed ID: 17179913
[TBL] [Abstract][Full Text] [Related]
8. FDG PET/CT findings of thymic carcinoid and bronchial carcinoid in a patient with multiple neuroendocrine neoplasia type1.
Abe T; Sato M; Okumura T; Shioyama Y; Kiyoshima M; Asato Y; Saito H; Iijima T; Amemiya R; Nagai H
Clin Nucl Med; 2008 Nov; 33(11):778-9. PubMed ID: 18936612
[No Abstract] [Full Text] [Related]
9. Prospective Comparison of 99mTc-MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT, and Whole-Body MRI in Patients with Breast and Prostate Cancer.
Minamimoto R; Loening A; Jamali M; Barkhodari A; Mosci C; Jackson T; Obara P; Taviani V; Gambhir SS; Vasanawala S; Iagaru A
J Nucl Med; 2015 Dec; 56(12):1862-8. PubMed ID: 26405167
[TBL] [Abstract][Full Text] [Related]
10. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
Ng SP; David S; Alamgeer M; Ganju V
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
[TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary carcinoid tumor and related cervical vertebral metastasis with PET-positive and octreotide-negative scintigraphy.
Nguyen BD; Ram PC
Clin Nucl Med; 2006 Feb; 31(2):101-3. PubMed ID: 16424699
[No Abstract] [Full Text] [Related]
12. Combination of (18)-FDG and (68)Ga-DOTATOC PET-CT to differentiate endobronchial carcinoids and inflammatory myofibroblastic tumors.
Jindal T; Kumar A; Dutta R; Kumar R
J Postgrad Med; 2009; 55(4):272-4. PubMed ID: 20083875
[TBL] [Abstract][Full Text] [Related]
13. Somatostatin receptor scintigraphy with 111In-octreotide in pulmonary carcinoid tumours correlated with pathological and 18FDG PET/CT findings.
Kuyumcu S; Adalet I; Sanli Y; Turkmen C; Ozkan ZG; Yilmazbayhan D
Ann Nucl Med; 2012 Nov; 26(9):689-97. PubMed ID: 22802007
[TBL] [Abstract][Full Text] [Related]
14. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
Krüger S; Buck AK; Blumstein NM; Pauls S; Schelzig H; Kropf C; Schumann C; Mottaghy FM; Hombach V; Reske SN
J Intern Med; 2006 Dec; 260(6):545-50. PubMed ID: 17116005
[TBL] [Abstract][Full Text] [Related]
15. F-18 FDG PET/CT imaging of low-grade mucoepidermoid carcinoma of the bronchus.
Ishizumi T; Tateishi U; Watanabe S; Maeda T; Arai Y
Ann Nucl Med; 2007 Jul; 21(5):299-302. PubMed ID: 17634848
[TBL] [Abstract][Full Text] [Related]
16. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
[TBL] [Abstract][Full Text] [Related]
17. Incidental finding of an endobronchial tumor by 18F-FDG PET/CT.
Navales I; Garcia JR; Alvarez-Moro FJ; Navarro A; Escobar I; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):271-2. PubMed ID: 23046638
[No Abstract] [Full Text] [Related]
18. AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.
Clapp AJ; Peller PJ; Subramaniam RM
AJR Am J Roentgenol; 2011 Jun; 196(6 Suppl):WS83-5. PubMed ID: 21606246
[No Abstract] [Full Text] [Related]
19. [Diagnosis and staging using spiral computed tomography of an endobronchial carcinoid tumor].
Coulier B; Mairesse M
JBR-BTR; 2000 Feb; 83(1):1-3. PubMed ID: 10769493
[TBL] [Abstract][Full Text] [Related]
20. Missed causative tumors in diagnosing tumor-induced osteomalacia with (18)F-FDG PET/CT: a potential pitfall of standard-field imaging.
Kaneuchi Y; Hakozaki M; Yamada H; Hasegawa O; Tajino T; Konno S
Hell J Nucl Med; 2016; 19(1):46-8. PubMed ID: 26929940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
